The restrained glycolysis and the inhibited AKT/GSK3β axis were rescued by IGFBP1 depletion in HCC cells (Figures 6E–G), indicating that CBD can regulate glycolysis via modulation of the IGFBP1/AKT/GSK3β axis. The gene discussed is GSK3B; the disease is hepatocellular carcinoma.